To investigate the underlying mechanism of ABT-263-induced Mcl-1 upregulation in HCC cells, both mRNA and protein levels of Mcl-1 were analyzed after treatment with ABT-263. This evidence concerns the gene MCL1 and hepatocellular carcinoma.